Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 11 of 11  Show
  1. 1
    "Molecular cloning and characterization of human chondrolectin, a novel type I transmembrane protein homologous to C-type lectins."
    Weng L., Smits P., Wauters J., Merregaert J.
    Genomics 80:62-70(2002) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY.
    Category: Expression, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 3 other entries.

  2. 2
    "A novel alternative spliced chondrolectin isoform lacking the transmembrane domain is expressed during T cell maturation."
    Weng L., Van Bockstaele D.R., Wauters J., Van Marck E., Plum J., Berneman Z.N., Merregaert J.
    J. Biol. Chem. 278:19164-19170(2003) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), ALTERNATIVE PROMOTER USAGE, SUBCELLULAR LOCATION (ISOFORMS 2 AND 3).
    Category: Subcellular Location, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  3. 3
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1015 other entries.

  4. 4
    "Complete sequencing and characterization of 21,243 full-length human cDNAs."
    Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.
    Sugano S.
    Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 4).
    Category: Sequences.
    Tissue: Brain.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 12931 other entries.

  5. 5
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 609 other entries.

  6. 6
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 3834 other entries.

  7. 7
    "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
    Category: Sequences.
    Tissue: Brain.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 50469 other entries.

  8. 8
    "From PREDs and open reading frames to cDNA isolation: revisiting the human chromosome 21 transcription map."
    Reymond A., Friedli M., Neergaard Henrichsen C., Chapot F., Deutsch S., Ucla C., Rossier C., Lyle R., Guipponi M., Antonarakis S.E.
    Genomics 78:46-54(2001) [PubMed] [Europe PMC] [Abstract]
    Cited for: TISSUE SPECIFICITY.
    Category: Expression.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 21 and mapped to 21 other entries.

  9. 9
    Cited for: SUBCELLULAR LOCATION, MISCELLANEOUS.
    Category: Subcellular Location.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 4 other entries.

  10. 10
    "Expression and localization of CHODLDeltaE/CHODLfDeltaE, the soluble isoform of chondrolectin."
    Claessens A., Van de Vijver K., Van Bockstaele D.R., Wauters J., Berneman Z.N., Van Marck E., Merregaert J.
    Cell Biol. Int. 31:1323-1330(2007) [PubMed] [Europe PMC] [Abstract]
    Category: Subcellular Location, Sequences.
    Annotation: CHODLDeltaE/CHODLfDeltaE protein variant localizes in the late endoplasmic reticulum and is detected in spleen and tonsils; the isoform seems to be differentially expressed in thymocytes and lymphocytes.Imported.
    Source: GeneRIF:140578.

    This publication is mapped to 1 other entry.

  11. 11
    "Chondrolectin is a novel diagnostic biomarker and a therapeutic target for lung cancer."
    Masuda K., Takano A., Oshita H., Akiyama H., Tsuchiya E., Kohno N., Nakamura Y., Daigo Y.
    Clin. Cancer Res. 17:7712-7722(2011) [PubMed] [Europe PMC] [Abstract]
    Annotation: Data indicate that chondrolectin (CHODL) is likely to be a prognostic biomarker in the clinic and targeting CHODL might be a strategy for the development of anticancer drugs.Imported.
    Source: GeneRIF:140578.

    This publication is mapped to 1 other entry.

1 to 11 of 11  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again